# Eden Bio

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/eden-bio

- Industry: Biotechnology
- Headquarters: London, UK
- Website: www.eden.bio
- Total disclosed funding: $1.2M
- Latest round: Seed (Nov 9, 2022)
- Investors on record: 3

## About

Founded in 2021 by Christopher Reynolds (CTO), Rachel Shaw (CEO), and Evgenia Markova, and based in England, UK, Eden Bio Ltd operates as a biotechnology research company that helps fermentation companies to genetically optimize microorganism strains and improve the yield of protein products. In November 2022, Eden Bio Ltd raised GBP 1 million in seed funding led by investor SynBioVen, with participation from Dhyana Capital and Saras Capital.



The company employs machine learning to help companies improve protein yield used in the production of industrial enzymes, therapeutics, vegan foods, custom proteins, or media components. The firm offers precision fermentation and tailored microorganisms as cell factories to produce optimized ingredients with protein-producing microorganism strains.



The company intends to use the November 2022 funding to accelerate the growth of capacity and ability of the platform to improve the yield of protein products by using artificial intelligence.

## Funding rounds

- Seed, Nov 9, 2022, $1.2M — Saras Capital, Dhyana Capital, SynBioVen

## Investors

- Saras Capital (https://capitalatlas.ai/funds/saras-capital) — Seed
- Dhyana Capital — Seed
- SynBioVen (https://capitalatlas.ai/funds/synbioven) — Seed